Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations-Reference-Cited by-同舟云学术

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations

Published:2019-07 Issue: Volume:154 Page:27-33
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Djamin Remco S.,Bafadhel Mona^ORCID,Uzun Sevim,Russell Richard E.K.,Ermens Anton A.M.,Kerstens Rene,Aerts Joachim G.J.V.,Pavord Ian D.,van der Eerden Menno M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference39 articles.

1. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality;Suissa;Thorax,2012

2. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD;Miravitlles;Chest,2002

3. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease;Donaldson;Thorax,2002

4. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations;Seemungal;Am. J. Respir. Crit. Care Med.,2008

5. Azithromycin for prevention of exacerbations of COPD;Albert;N. Engl. J. Med.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolides and Diseases Associated with Loss of Epithelial Barrier Integrity;Progress in Inflammation Research;2024

2. Prospects for macrolide therapy of asthma and COPD;Advances in Pharmacology;2023

3. Treating patients with acute COPD in the ED;JAAPA;2022-06

4. Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021;Revue des Maladies Respiratoires;2021-05